Immunogen, inc. announces results from trastuzumab emtansine (t-dm1) emilia phase iii trial Full Text
ImmunoGen, Inc., 06/04/2012

1 Boehringer Ingelheim responds to fda warning letter Full Text Boehringer Ingelheim, May 23, 2013    Free full text

2 FDA announces compounding pharmacy recall Full Text American Hospital Association News, May 3, 2013    Free full text

3 FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease Full Text FDA Press Announcements, May 13, 2013    Free full text

4 Daratumumab Receives Breakthrough Therapy Designation from US Food and Drug Administration Full Text Genmab, May 6, 2013    Free full text

5 FDA approves ACTEMRA for children living with a rare form of arthritis Full Text Roche, May 2, 2013    Free full text

6 FDA alerts providers to recall by drug compounder Full Text American Hospital Association News, May 21, 2013    Free full text

7 FDA Approves Mercks LIPTRUZET (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol Full Text Merck, May 6, 2013    Free full text

8 FDA allows marketing of first a1c test labeled for diagnosing diabetes Full Text FDA Press Announcements, May 28, 2013    Free full text

9 Fda approves two drugs, companion diagnostic test for advanced skin cancer Full Text FDA Press Announcements, May 30, 2013    Free full text

10 FDA alerts providers to mattress cover safety risks Full Text American Hospital Association News, April 29, 2013    Free full text

11 Free drugs in clinical trials and their potential cost saving impact on the National Health Service: A retrospective cost analysis in Italy Lung Cancer, May 8, 2013    Review Article

12 Astellas pharma global development announces management reorganization Full Text Astellas, April 3, 2013    Free full text

13 FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death Full Text FDA What's New: Drugs, May 1, 2013    Free full text

14 FDA approves new drug for advanced prostate cancer Full Text FDA Press Announcements, May 17, 2013    Free full text

15 Providers pulling back on it outsourcing due to regulatory control Full Text Healthcare Informatics, May 24, 2013    Free full text

16 Should regulation of combination products become more centralized in Europe Full Text BioPharm International, May 24, 2013    Free full text

17 FDA warns consumers about potential health risk with Juices Incorporated juice products Full Text FDA Press Announcements, May 13, 2013    Free full text

18 Infliximab for Treatment-Resistant Depression Full Text First Report Managed Care, May 13, 2013    Free full text

19 Myriad to Present New Molecular Data for Patients With Prostate Cancer at the American Urological Association 2013 Annual Meeting Full Text Myriad Genetics, May 3, 2013    Free full text

20 PROVENGE (sipuleucel-T) Data Presented at An Annual Scientific Urology Meeting Full Text Dendreon Coproration, May 7, 2013    Free full text